{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T17:56:16Z","timestamp":1778694976921,"version":"3.51.4"},"reference-count":43,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1124\/mol.119.118216","type":"journal-article","created":{"date-parts":[[2020,1,31]],"date-time":"2020-01-31T15:15:11Z","timestamp":1580483711000},"page":"259-266","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Epigenetic Mechanisms Underlying Organic Solute Transporter \u03b2 Repression in Colorectal Cancer"],"prefix":"10.1016","volume":"97","author":[{"given":"Ying","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaonan","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Lou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junqing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinxiu","family":"Lei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suhang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lushan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/mol.119.118216_bib1","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/1477-7819-12-164","article-title":"Secondary bile acids: an underrecognized cause of colon cancer","volume":"12","author":"Ajouz","year":"2014","journal-title":"World J Surg Oncol"},{"key":"10.1124\/mol.119.118216_bib2","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1002\/hep.20961","article-title":"OSTalpha-OSTbeta: a major basolateral bile acid and steroid transporter in human intestinal, renal, and biliary epithelia","volume":"42","author":"Ballatori","year":"2005","journal-title":"Hepatology"},{"key":"10.1124\/mol.119.118216_bib3","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.mam.2012.11.005","article-title":"The heteromeric organic solute transporter, OST\u03b1-OST\u03b2\/SLC51: a transporter for steroid-derived molecules","volume":"34","author":"Ballatori","year":"2013","journal-title":"Mol Aspects Med"},{"key":"10.1124\/mol.119.118216_bib4","doi-asserted-by":"crossref","first-page":"G179","DOI":"10.1152\/ajpgi.90319.2008","article-title":"Ostalpha-Ostbeta is required for bile acid and conjugated steroid disposition in the intestine, kidney, and liver","volume":"295","author":"Ballatori","year":"2008","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1124\/mol.119.118216_bib5","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.2741\/3416","article-title":"OST alpha-OST beta: a key membrane transporter of bile acids and conjugated steroids","volume":"14","author":"Ballatori","year":"2009","journal-title":"Front Biosci"},{"key":"10.1124\/mol.119.118216_bib6","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s00204-011-0648-7","article-title":"Carcinogenicity of deoxycholate, a secondary bile acid","volume":"85","author":"Bernstein","year":"2011","journal-title":"Arch Toxicol"},{"key":"10.1124\/mol.119.118216_bib7","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1101\/gad.947102","article-title":"DNA methylation patterns and epigenetic memory","volume":"16","author":"Bird","year":"2002","journal-title":"Genes Dev"},{"key":"10.1124\/mol.119.118216_bib8","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.chembiol.2010.03.006","article-title":"Virtual ligand screening of the p300\/CBP histone acetyltransferase: identification of a selective small molecule inhibitor","volume":"17","author":"Bowers","year":"2010","journal-title":"Chem Biol"},{"key":"10.1124\/mol.119.118216_bib9","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/S0140-6736(13)61649-9","article-title":"Colorectal cancer","volume":"383","author":"Brenner","year":"2014","journal-title":"Lancet"},{"key":"10.1124\/mol.119.118216_bib10","doi-asserted-by":"crossref","first-page":"366","DOI":"10.3322\/caac.20038","article-title":"Worldwide variations in colorectal cancer","volume":"59","author":"Center","year":"2009","journal-title":"CA Cancer J Clin"},{"key":"10.1124\/mol.119.118216_bib11","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.apsb.2019.01.002","article-title":"Upregulation of miR-489-3p and miR-630 inhibits oxaliplatin uptake in renal cell carcinoma by targeting OCT2","volume":"9","author":"Chen","year":"2019","journal-title":"Acta Pharm Sin B"},{"key":"10.1124\/mol.119.118216_bib12","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1194\/jlr.R900010-JLR200","article-title":"Bile acids: regulation of synthesis","volume":"50","author":"Chiang","year":"2009","journal-title":"J Lipid Res"},{"key":"10.1124\/mol.119.118216_bib13","doi-asserted-by":"crossref","first-page":"21233","DOI":"10.1074\/jbc.M112.352245","article-title":"\u03b2-Subunit of the Ost\u03b1-Ost\u03b2 organic solute transporter is required not only for heterodimerization and trafficking but also for function","volume":"287","author":"Christian","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.119.118216_bib14","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.biocel.2008.05.026","article-title":"Zn(II)-dependent histone deacetylase inhibitors: suberoylanilide hydroxamic acid and trichostatin A","volume":"41","author":"Codd","year":"2009","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1124\/mol.119.118216_bib15","doi-asserted-by":"crossref","first-page":"24","DOI":"10.4103\/2277-9175.108005","article-title":"The effect of CTB on P53 protein acetylation and consequence apoptosis on MCF-7 and MRC-5 cell lines","volume":"2","author":"Dastjerdi","year":"2013","journal-title":"Adv Biomed Res"},{"key":"10.1124\/mol.119.118216_bib16","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1194\/jlr.R900012-JLR200","article-title":"Bile acid transporters","volume":"50","author":"Dawson","year":"2009","journal-title":"J Lipid Res"},{"key":"10.1124\/mol.119.118216_bib17","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1471-4159.2010.06920.x","article-title":"Neurosteroid transport by the organic solute transporter OST\u03b1-OST\u03b2","volume":"115","author":"Fang","year":"2010","journal-title":"J Neurochem"},{"key":"10.1124\/mol.119.118216_bib18","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s13287-016-0439-4","article-title":"Bile acid: a potential inducer of colon cancer stem cells","volume":"7","author":"Farhana","year":"2016","journal-title":"Stem Cell Res Ther"},{"key":"10.1124\/mol.119.118216_bib19","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s13304-016-0359-y","article-title":"Worldwide burden of colorectal cancer: a review","volume":"68","author":"Favoriti","year":"2016","journal-title":"Updates Surg"},{"key":"10.1124\/mol.119.118216_bib20","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/ardp.201100209","article-title":"Small molecule inhibitors of histone acetyltransferases as epigenetic tools and drug candidates","volume":"345","author":"Furdas","year":"2012","journal-title":"Arch Pharm (Weinheim)"},{"key":"10.1124\/mol.119.118216_bib21","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.mam.2017.04.002","article-title":"Bile acids and colon cancer: is FXR the solution of the conundrum?","volume":"56","author":"Gadaleta","year":"2017","journal-title":"Mol Aspects Med"},{"key":"10.1124\/mol.119.118216_bib22","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1756-8935-8-9","article-title":"Altering cancer transcriptomes using epigenomic inhibitors","volume":"8","author":"Gaddis","year":"2015","journal-title":"Epigenetics Chromatin"},{"key":"10.1124\/mol.119.118216_bib23","doi-asserted-by":"crossref","first-page":"18","DOI":"10.4161\/trns.22601","article-title":"Genomic occupancy of the transcriptional co-activators p300 and CBP","volume":"4","author":"Holmqvist","year":"2013","journal-title":"Transcription"},{"key":"10.1124\/mol.119.118216_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/pr.109.002014","article-title":"Xenobiotic, bile acid, and cholesterol transporters: function and regulation","volume":"62","author":"Klaassen","year":"2010","journal-title":"Pharmacol Rev"},{"key":"10.1124\/mol.119.118216_bib25","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/nprot.2006.98","article-title":"Chromatin immunoprecipitation and microarray-based analysis of protein location","volume":"1","author":"Lee","year":"2006","journal-title":"Nat Protoc"},{"key":"10.1124\/mol.119.118216_bib26","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf3124","article-title":"Epigenetic activation of the drug transporter OCT2 sensitizes renal cell carcinoma to oxaliplatin","volume":"8","author":"Liu","year":"2016","journal-title":"Sci Transl Med"},{"key":"10.1124\/mol.119.118216_bib27","doi-asserted-by":"crossref","first-page":"4527","DOI":"10.1021\/jp067655s","article-title":"Activation of p300 histone acetyltransferase by small molecules altering enzyme structure: probed by surface-enhanced Raman spectroscopy","volume":"111","author":"Mantelingu","year":"2007","journal-title":"J Phys Chem B"},{"key":"10.1124\/mol.119.118216_bib28","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrc1779","article-title":"Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer","volume":"6","author":"Minucci","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"10.1124\/mol.119.118216_bib29","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1093\/jnci\/53.4.1093","article-title":"Promoting effect of bile acids on colon carcinogenesis after intrarectal instillation of N-methyl-N\u2019-nitro-N-nitrosoguanidine in rats","volume":"53","author":"Narisawa","year":"1974","journal-title":"J Natl Cancer Inst"},{"key":"10.1124\/mol.119.118216_bib30","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.canlet.2014.08.010","article-title":"Decitabine, a new star in epigenetic therapy: the clinical application and biological mechanism in solid tumors","volume":"354","author":"Nie","year":"2014","journal-title":"Cancer Lett"},{"key":"10.1124\/mol.119.118216_bib31","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1053\/j.gastro.2015.07.011","article-title":"Epigenetic alterations in colorectal cancer: emerging biomarkers","volume":"149","author":"Okugawa","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1124\/mol.119.118216_bib32","doi-asserted-by":"crossref","first-page":"33","DOI":"10.7453\/gahmj.2014.021","article-title":"Three measurable and modifiable enteric microbial biotransformations relevant to cancer prevention and treatment","volume":"3","author":"Plotnikoff","year":"2014","journal-title":"Glob Adv Health Med"},{"key":"10.1124\/mol.119.118216_bib33","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1016\/j.celrep.2018.07.041","article-title":"Enhancer activity requires CBP\/P300 bromodomain-dependent histone H3K27 acetylation","volume":"24","author":"Raisner","year":"2018","journal-title":"Cell Rep"},{"key":"10.1124\/mol.119.118216_bib34","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1093\/carcin\/bgv107","article-title":"Slc10a2-null mice uncover colon cancer-promoting actions of endogenous fecal bile acids","volume":"36","author":"Raufman","year":"2015","journal-title":"Carcinogenesis"},{"key":"10.1124\/mol.119.118216_bib35","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a018713","article-title":"Erasers of histone acetylation: the histone deacetylase enzymes","volume":"6","author":"Seto","year":"2014","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1124\/mol.119.118216_bib36","doi-asserted-by":"crossref","first-page":"27473","DOI":"10.1074\/jbc.M301106200","article-title":"Functional complementation between a novel mammalian polygenic transport complex and an evolutionarily ancient organic solute transporter, OSTalpha-OSTbeta","volume":"278","author":"Seward","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.119.118216_bib37","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3390\/ijms17010099","article-title":"The functional analysis of histone acetyltransferase MOF in tumorigenesis","volume":"17","author":"Su","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1124\/mol.119.118216_bib38","doi-asserted-by":"crossref","first-page":"9431","DOI":"10.1073\/pnas.161099898","article-title":"Expression cloning of two genes that together mediate organic solute and steroid transport in the liver of a marine vertebrate","volume":"98","author":"Wang","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.119.118216_bib39","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.cell.2009.06.049","article-title":"Genome-wide mapping of HATs and HDACs reveals distinct functions in active and inactive genes","volume":"138","author":"Wang","year":"2009","journal-title":"Cell"},{"key":"10.1124\/mol.119.118216_bib40","doi-asserted-by":"crossref","first-page":"412","DOI":"10.2337\/db17-0237","article-title":"The p300 and CBP transcriptional coactivators are required for \u03b2-cell and \u03b1-cell proliferation","volume":"67","author":"Wong","year":"2018","journal-title":"Diabetes"},{"key":"10.1124\/mol.119.118216_bib41","doi-asserted-by":"crossref","first-page":"4209","DOI":"10.1111\/bph.14467","article-title":"Inhibition of histone deacetylase 7 reverses concentrative nucleoside transporter 2 repression in colorectal cancer by up-regulating histone acetylation state","volume":"175","author":"Ye","year":"2018","journal-title":"Br J Pharmacol"},{"key":"10.1124\/mol.119.118216_bib42","doi-asserted-by":"crossref","first-page":"D1042","DOI":"10.1093\/nar\/gkz779","article-title":"VARIDT 1.0: variability of drug transporter database","volume":"48","author":"Yin","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"10.1124\/mol.119.118216_bib43","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1080\/15592294.2019.1615354","article-title":"OCT2 transcriptional repression by histone acetylation in renal cell carcinoma","volume":"14","author":"Zhu","year":"2019","journal-title":"Epigenetics"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24009970?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24009970?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.119.118216","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T10:32:39Z","timestamp":1739961159000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24009970"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S0026895X24009970"],"URL":"https:\/\/doi.org\/10.1124\/mol.119.118216","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epigenetic Mechanisms Underlying Organic Solute Transporter \u03b2 Repression in Colorectal Cancer","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.119.118216","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}